ro 31-8220 has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Ro 31-8220: a protein kinase C inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snowden, RT | 1 |
| Sun, XM | 1 |
| Dyer, MJ | 1 |
| Cohen, GM | 1 |
1 other study available for ro 31-8220 and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1.
Topics: Apoptosis; B-Lymphocytes; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Caspases; Humans; Indole | 2003 |